Showing 1,141 - 1,160 results of 28,372 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 5 ((ng decrease) OR (teer decrease)) ))', query time: 0.64s Refine Results
  1. 1141

    HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

    Published 2021
    “…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …”
  2. 1142
  3. 1143

    Typical structure of a centrifugal nozzle [25]. by Yanyu Cui (19173181)

    Published 2025
    “…As temperature rises from 0°C to 50°C, liquid film thickness decreases, with a reduction of 14.6% for low-blending fuel and 52.8% for high-blending fuel.…”
  4. 1144
  5. 1145
  6. 1146

    Inhibitory dose of CAP (ID<sub>50</sub>). by Alan Siu (756300)

    Published 2015
    “…<p>Duration of CAP treatment necessary to decrease viability by 50%, termed the inhibitory duration (ID<sub><b>50</b></sub>). …”
  7. 1147
  8. 1148
  9. 1149
  10. 1150
  11. 1151

    Proliferative tissue degeneration is accompanied by a sustained decrease in proliferation, acute apoptotic responses, and progressive accumulation of DDR foci. by Catarina M. Henriques (102294)

    Published 2013
    “…Proliferative tissues such as A) testes, B) head kidney and C) gut sections show sustained significant decrease in proliferation in <i>tert<sup>−/−</sup></i> as compared to <i>tert<sup>+/+</sup></i> siblings (panels b, d and e) (p<0.001) and an acute apoptotic response at 3 months of age (p<0.001), which clears by c. 12 months (panels g, i and j). …”
  12. 1152
  13. 1153
  14. 1154
  15. 1155
  16. 1156
  17. 1157
  18. 1158

    Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

    Published 2013
    “…The pre-defined secondary outcomes were better in the Tac group compared to the control group. The frequency of decrease in pcUACR and percentage change of UPCR (pcUPCR) ≥50% at 16 weeks were 65.0% (13/20) and 55.0% (11/20)in the Tac group, and 25.0% (5/20) and 15.0% (3/20), in the control group, respectively (p = 0.025 for pcUACR and p = 0.019 for pcUPCR). …”
  19. 1159
  20. 1160